InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.735
-0.005 (-0.29%)
Nov 4, 2024, 3:59 PM EST - Market closed
InterCure Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 272.67 | 355.55 | 388.68 | 219.68 | 65.04 | 8.93 | Upgrade
|
Revenue Growth (YoY) | -34.26% | -8.52% | 76.93% | 237.78% | 628.60% | - | Upgrade
|
Cost of Revenue | 194.7 | 246.95 | 216.67 | 117.11 | 31.45 | 4.38 | Upgrade
|
Gross Profit | 77.98 | 108.6 | 172.01 | 102.56 | 33.59 | 4.55 | Upgrade
|
Selling, General & Admin | 92.05 | 95.88 | 92.62 | 50.42 | 17.03 | 14.77 | Upgrade
|
Research & Development | 0.35 | 0.39 | 0.63 | 1.24 | 1.58 | 1.71 | Upgrade
|
Other Operating Expenses | -12.38 | 11.24 | 29 | 14.4 | 6.18 | 2.91 | Upgrade
|
Operating Expenses | 80.95 | 110.1 | 131.16 | 72.51 | 34.79 | 87.43 | Upgrade
|
Operating Income | -2.97 | -1.5 | 40.85 | 30.05 | -1.21 | -82.88 | Upgrade
|
Interest Expense | - | -0.73 | -0.63 | -0.42 | -0.26 | -1.84 | Upgrade
|
Interest & Investment Income | 5.2 | 5.38 | 0.84 | 0.13 | 0.02 | 0.14 | Upgrade
|
Earnings From Equity Investments | - | - | - | - | - | -0.34 | Upgrade
|
Currency Exchange Gain (Loss) | -0.05 | -0.05 | 7.33 | -4.54 | 0.6 | -1.32 | Upgrade
|
Other Non Operating Income (Expenses) | -24.32 | -24.32 | -14.33 | -4.63 | -0.26 | -0.13 | Upgrade
|
EBT Excluding Unusual Items | -22.14 | -21.22 | 34.07 | 20.6 | -1.11 | -86.37 | Upgrade
|
Merger & Restructuring Charges | -0.36 | -0.36 | -0.63 | - | - | - | Upgrade
|
Impairment of Goodwill | -63.1 | -63.1 | - | - | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | -2.78 | -3 | -0.17 | -1.87 | -37.2 | 79.8 | Upgrade
|
Asset Writedown | -4.59 | -4.59 | - | - | - | - | Upgrade
|
Other Unusual Items | 30.98 | 30.98 | 10.57 | - | - | - | Upgrade
|
Pretax Income | -61.99 | -61.29 | 43.84 | 18.73 | -38.31 | -6.57 | Upgrade
|
Income Tax Expense | 5.37 | 2.25 | 0.09 | 11.44 | -2.27 | -0.67 | Upgrade
|
Earnings From Continuing Operations | -67.36 | -63.53 | 43.75 | 7.29 | -36.04 | -5.89 | Upgrade
|
Minority Interest in Earnings | 1.73 | 1.57 | 1.07 | -2.6 | -1.19 | - | Upgrade
|
Net Income | -65.62 | -61.96 | 44.82 | 4.69 | -37.23 | -5.89 | Upgrade
|
Net Income to Common | -65.62 | -61.96 | 44.82 | 4.69 | -37.23 | -5.89 | Upgrade
|
Net Income Growth | - | - | 855.63% | - | - | - | Upgrade
|
Shares Outstanding (Basic) | 46 | 46 | 45 | 38 | 25 | 23 | Upgrade
|
Shares Outstanding (Diluted) | 46 | 46 | 45 | 41 | 25 | 23 | Upgrade
|
Shares Change (YoY) | 0.82% | 0.37% | 11.18% | 60.81% | 9.00% | 29.71% | Upgrade
|
EPS (Basic) | -1.42 | -1.36 | 0.99 | 0.12 | -1.47 | -0.25 | Upgrade
|
EPS (Diluted) | -1.42 | -1.36 | 0.99 | 0.11 | -1.47 | -0.25 | Upgrade
|
EPS Growth | - | - | 798.39% | - | - | - | Upgrade
|
Free Cash Flow | - | -56.25 | 31.53 | 16.11 | -12.95 | -39.71 | Upgrade
|
Free Cash Flow Per Share | - | -1.23 | 0.69 | 0.39 | -0.51 | -1.70 | Upgrade
|
Gross Margin | 28.60% | 30.54% | 44.25% | 46.69% | 51.65% | 50.93% | Upgrade
|
Operating Margin | -1.09% | -0.42% | 10.51% | 13.68% | -1.85% | -928.51% | Upgrade
|
Profit Margin | -24.07% | -17.43% | 11.53% | 2.13% | -57.25% | -66.02% | Upgrade
|
Free Cash Flow Margin | - | -15.82% | 8.11% | 7.33% | -19.90% | -444.91% | Upgrade
|
EBITDA | 2.95 | 6.68 | 48.34 | 37.45 | 2.05 | -82.05 | Upgrade
|
EBITDA Margin | 1.08% | 1.88% | 12.44% | 17.05% | 3.15% | - | Upgrade
|
D&A For EBITDA | 5.92 | 8.18 | 7.48 | 7.39 | 3.25 | 0.83 | Upgrade
|
EBIT | -2.97 | -1.5 | 40.85 | 30.05 | -1.21 | -82.88 | Upgrade
|
EBIT Margin | -1.09% | -0.42% | 10.51% | 13.68% | -1.85% | - | Upgrade
|
Effective Tax Rate | - | - | 0.21% | 61.07% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.